Last close As at 05/08/2026
GBP0.37
▲ −0.30 (−0.80%)
Market capitalisation
GBP111m
Research: Industrials
Severfield continues to trade in line with existing expectations though adverse sector sentiment has weighed on the company’s share price. There is a healthy and normal level of forward order cover and we believe that the project pipeline is likely to contain some good new project prospects. Overall, the AGM update provided reassurance for wary investors and, in our view, encouragement for potential new ones.
Written by
Severfield |
Reassurance and encouragement |
AGM update |
Construction & materials |
12 September 2017 |
Share price performance
Business description
Next events
Analysts
|
||||||||||||||||||||||||||||||||||||||||||||||||
Severfield continues to trade in line with existing expectations though adverse sector sentiment has weighed on the company’s share price. There is a healthy and normal level of forward order cover and we believe that the project pipeline is likely to contain some good new project prospects. Overall, the AGM update provided reassurance for wary investors and, in our view, encouragement for potential new ones.
Year end |
Revenue (£m) |
PBT* |
EPS* |
DPS |
P/E |
Yield |
03/16 |
239.4 |
13.7 |
3.8 |
1.5 |
16.5 |
2.4 |
03/17 |
262.2 |
20.3 |
5.7 |
2.3 |
11.0 |
3.7 |
03/18e |
263.2 |
22.2 |
6.3 |
2.5 |
9.9 |
4.0 |
03/19e |
267.8 |
24.4 |
6.9 |
2.8 |
9.1 |
4.5 |
Note: *PBT and EPS are normalised, excluding pension net finance costs, intangible amortisation and exceptional items.
Positive order book interpretations
Severfield’s AGM update noted the likelihood of a greater H1 – and implicitly more even full year – weighting to FY18 results compared to the prior year (FY17 EBIT H1:H2, 42:58). We assume that this reflects the pattern of projects at or nearing completion and is consistent with higher activity levels seen last year. The UK order book value is slightly below the last reported level at £221m. (This provides forward cover for all four UK fabrication facilities, naturally longer for some reflecting underlying project characteristics.) As well as the cycle through of orders this could be interpreted as a signal of slowing markets and/or more protracted tender processes. On the other hand, it could also signify a reaffirmation of Severfield’s ongoing project selectivity, possibly with a view to securing visible pipeline opportunities in the context of available capacity. The company’s bid conversion rate is understood to have been very consistent and stable in the year to date. We believe that the pipeline of larger UK project prospects is significant and spread across a number of segments addressed. These include London commercial and retail and, on a slightly longer view, infrastructure and stadia. The UK order book could well gap up again over the next 12-18 months (as seen in H116 and H117) in our view. The Indian JV order book at £64m is lower than last reported but against historical levels (in the £30-40m range) and local fabrication capacity this still represents a healthy level. Recent equity injections by both JV partners (to re-finance debt) indicated confidence in future prospects and this is unchanged.
Valuation: Rating compression, decent yield
After reaching an intra-year high of 88p in April, Severfield’s share price has trended lower and is now down c 15% ytd, while the FTSE All Share Index is up c 4%. Our PBT, EPS and especially DPS estimates have increased over this time period in all forecast years, although are unchanged for the AGM update. Consequently, current year P/E and EV/EBITDA multiples have compressed to 9.9x and 5.6x, respectively, and decline further by FY20. A prospective yield of 4% further enhances potential shareholder returns.
Exhibit 1: Financial summary
£m |
2010 |
2011 |
2012 |
2013 |
2014 |
2015 |
2016 |
2017 |
2018e |
2019e |
2020e |
||||
Year end 31 March |
IFRS |
IFRS |
IFRS |
IFRS |
IFRS |
IFRS |
IFRS |
IFRS |
IFRS |
IFRS |
IFRS |
||||
12m to Dec |
12m to Dec |
12m to Dec |
15m to Mar |
12m to Mar |
12m to Mar |
12m to Mar |
12m to Mar |
12m to Mar |
12m to Mar |
12m to Mar |
|||||
PROFIT & LOSS |
|||||||||||||||
Revenue |
|
|
266.7 |
267.8 |
256.6 |
318.3 |
231.3 |
201.5 |
239.4 |
262.2 |
263.2 |
267.8 |
274.1 |
||
Cost of Sales |
(242.6) |
(246.9) |
(268.8) |
(330.9) |
(217.8) |
(186.7) |
(219.6) |
(236.3) |
(235.7) |
(238.0) |
(242.2) |
||||
Gross Profit |
24.1 |
20.9 |
(12.2) |
(12.7) |
13.5 |
14.9 |
19.8 |
25.9 |
27.5 |
29.7 |
32.0 |
||||
EBITDA |
|
|
21.6 |
19.5 |
(13.6) |
(13.6) |
12.0 |
13.6 |
18.9 |
25.7 |
27.3 |
29.6 |
31.9 |
||
Operating Profit - Edison |
|
|
17.1 |
15.0 |
(17.7) |
(18.6) |
8.4 |
10.0 |
15.2 |
22.1 |
23.5 |
25.5 |
27.6 |
||
Net Interest |
(0.9) |
(1.6) |
(1.6) |
(2.0) |
(0.6) |
(0.5) |
(0.2) |
(0.2) |
(0.1) |
0.0 |
0.1 |
||||
Associates |
(0.4) |
(2.5) |
0.2 |
(0.3) |
(3.0) |
(0.2) |
(0.2) |
0.5 |
0.8 |
0.9 |
1.0 |
||||
SBP |
(0.0) |
(0.3) |
(0.0) |
(0.1) |
(0.2) |
(0.5) |
(1.1) |
(2.0) |
(2.0) |
(2.0) |
(2.0) |
||||
Intangible Amortisation |
(2.7) |
(2.7) |
(2.7) |
(3.5) |
(2.7) |
(2.6) |
(2.6) |
(2.6) |
(1.6) |
0.0 |
0.0 |
||||
Pension Net Finance Costs |
(0.5) |
(0.5) |
(0.5) |
(0.6) |
(0.5) |
(0.5) |
(0.5) |
(0.5) |
(0.5) |
(0.5) |
(0.5) |
||||
Exceptionals |
(1.4) |
(0.6) |
(1.0) |
(3.8) |
(5.3) |
(5.9) |
(0.9) |
0.8 |
0.0 |
0.0 |
0.0 |
||||
Profit Before Tax (norm) - Edison |
|
15.8 |
10.6 |
(19.1) |
(20.9) |
4.5 |
8.8 |
13.7 |
20.3 |
22.2 |
24.4 |
26.6 |
|||
Profit Before Tax (norm) |
|
|
15.3 |
10.1 |
(19.6) |
(21.5) |
4.0 |
8.3 |
13.2 |
19.8 |
21.7 |
23.9 |
26.1 |
||
Profit Before Tax (FRS 3) |
|
|
11.1 |
6.8 |
(23.3) |
(28.9) |
(4.1) |
(0.2) |
9.6 |
18.1 |
20.2 |
23.9 |
26.1 |
||
Tax |
(3.5) |
(0.9) |
3.9 |
5.7 |
1.4 |
0.3 |
(1.0) |
(2.7) |
(3.6) |
(3.9) |
(4.3) |
||||
Profit After Tax (norm) |
11.7 |
7.7 |
(16.2) |
(17.9) |
3.1 |
7.4 |
11.4 |
17.0 |
18.7 |
20.5 |
22.4 |
||||
Profit After Tax (FRS 3) |
7.6 |
5.8 |
(19.4) |
(23.1) |
(2.6) |
0.1 |
8.6 |
15.3 |
16.6 |
20.0 |
21.9 |
||||
Average Number of Shares Outstanding (m) |
89.0 |
89.3 |
89.3 |
89.3 |
295.8 |
297.5 |
297.5 |
298.9 |
298.5 |
298.5 |
298.5 |
||||
EPS - normalised (p) - Edison |
|
|
6.82 |
4.51 |
(9.42) |
(10.42) |
1.05 |
2.47 |
3.84 |
5.70 |
6.26 |
6.87 |
7.49 |
||
EPS - normalised (p) |
|
|
6.51 |
4.21 |
(9.72) |
(9.45) |
0.88 |
2.31 |
3.67 |
5.53 |
6.09 |
6.70 |
7.32 |
||
EPS - FRS 3 (p) |
|
|
4.47 |
3.41 |
(11.33) |
(13.49) |
(0.89) |
0.05 |
2.89 |
5.13 |
5.56 |
6.70 |
7.32 |
||
Dividend per share (p) |
7.5 |
5.0 |
1.5 |
0.8 |
0.0 |
0.5 |
1.5 |
2.3 |
2.5 |
2.8 |
3.0 |
||||
Gross Margin (%) |
9.0 |
7.8 |
-4.8 |
-4.0 |
5.8 |
7.4 |
8.3 |
9.9 |
10.4 |
11.1 |
11.7 |
||||
EBITDA Margin (%) |
8.1 |
7.3 |
-5.3 |
-4.3 |
5.2 |
6.7 |
7.9 |
9.8 |
10.4 |
11.1 |
11.6 |
||||
Operating Margin - Edison (%) |
6.4 |
5.6 |
-6.9 |
-5.8 |
3.6 |
4.9 |
6.4 |
8.4 |
8.9 |
9.5 |
10.1 |
||||
BALANCE SHEET |
|||||||||||||||
Fixed Assets |
|
|
165.0 |
156.9 |
155.6 |
154.9 |
147.7 |
145.1 |
149.3 |
148.3 |
154.5 |
156.8 |
159.0 |
||
Intangible Assets |
75.2 |
72.9 |
70.4 |
69.8 |
64.6 |
61.8 |
59.2 |
56.3 |
54.7 |
54.7 |
54.7 |
||||
Tangible Assets |
82.9 |
79.6 |
76.2 |
76.1 |
74.1 |
76.6 |
77.4 |
78.9 |
80.6 |
81.5 |
82.2 |
||||
Investments |
6.9 |
4.4 |
8.9 |
8.9 |
9.0 |
6.7 |
12.7 |
13.1 |
19.2 |
20.6 |
22.1 |
||||
Current Assets |
|
|
88.1 |
100.5 |
69.8 |
80.5 |
72.2 |
76.3 |
75.1 |
107.1 |
109.6 |
122.6 |
137.1 |
||
Stocks |
12.6 |
9.1 |
7.1 |
8.2 |
5.8 |
4.8 |
5.3 |
7.8 |
7.7 |
7.8 |
7.9 |
||||
Debtors |
71.9 |
89.2 |
61.2 |
71.6 |
60.8 |
64.6 |
50.7 |
66.5 |
67.5 |
69.2 |
71.3 |
||||
Cash |
3.6 |
2.3 |
1.4 |
0.7 |
5.5 |
6.9 |
19.0 |
32.8 |
34.4 |
45.6 |
57.8 |
||||
Current Liabilities |
|
|
(99.8) |
(103.6) |
(97.0) |
(112.5) |
(57.9) |
(59.7) |
(58.2) |
(78.7) |
(75.6) |
(76.5) |
(77.8) |
||
Creditors |
(81.2) |
(70.3) |
(66.1) |
(70.9) |
(52.7) |
(59.5) |
(58.1) |
(78.5) |
(75.4) |
(76.4) |
(77.6) |
||||
Short term borrowings |
(18.6) |
(33.3) |
(30.9) |
(41.7) |
(5.2) |
(0.2) |
(0.2) |
(0.2) |
(0.2) |
(0.2) |
(0.2) |
||||
Long Term Liabilities |
|
|
(22.3) |
(21.6) |
(21.7) |
(20.4) |
(18.5) |
(21.1) |
(17.9) |
(22.5) |
(22.5) |
(22.5) |
(22.5) |
||
Long term borrowings |
0.0 |
(0.3) |
(0.3) |
(0.2) |
(0.0) |
(0.6) |
(0.4) |
(0.2) |
(0.2) |
(0.2) |
(0.2) |
||||
Other long term liabilities |
(22.3) |
(21.3) |
(21.4) |
(20.2) |
(18.5) |
(20.5) |
(17.5) |
(22.3) |
(22.3) |
(22.3) |
(22.3) |
||||
Net Assets |
|
|
130.9 |
132.3 |
106.6 |
102.4 |
143.4 |
140.6 |
148.2 |
154.2 |
166.0 |
180.4 |
195.8 |
||
CASH FLOW |
|||||||||||||||
Operating Cash Flow |
|
|
(5.8) |
(5.4) |
12.9 |
3.1 |
2.1 |
11.4 |
24.8 |
27.4 |
22.0 |
27.9 |
30.0 |
||
Net Interest |
(0.8) |
(2.0) |
(1.3) |
(1.7) |
(0.8) |
(0.8) |
(0.2) |
(0.1) |
(0.1) |
0.0 |
0.1 |
||||
Tax |
(5.4) |
(3.7) |
(2.7) |
(2.3) |
0.4 |
(1.0) |
(0.9) |
(2.4) |
(2.9) |
(3.6) |
(3.9) |
||||
Capex |
(2.8) |
(1.5) |
(0.2) |
(1.4) |
(1.5) |
(1.3) |
(4.3) |
(5.3) |
(5.5) |
(5.0) |
(5.0) |
||||
Acquisitions/disposals |
(2.9) |
(0) |
(2) |
(3.0) |
(3.5) |
(1.7) |
(4.1) |
(0.4) |
(5.3) |
(0.5) |
(0.5) |
||||
Financing |
0 |
0 |
0 |
0.0 |
44.8 |
0 |
0 |
0 |
0 |
0 |
0 |
||||
Dividends |
(8.9) |
(3.6) |
(4.5) |
(4.5) |
0.0 |
0.0 |
(3.0) |
(5.1) |
(6.7) |
(7.7) |
(8.4) |
||||
Net Cash Flow |
(26.6) |
(16.3) |
1.7 |
(9.7) |
41.5 |
6.7 |
12.4 |
14.0 |
1.6 |
11.2 |
12.2 |
||||
Opening net debt/(cash) |
|
|
(11.5) |
15.0 |
31.3 |
31.3 |
41.2 |
(0.3) |
(6.1) |
(18.4) |
(32.4) |
(34.0) |
(45.2) |
||
HP finance leases initiated |
0 |
0.0 |
0.1 |
0.0 |
(0.2) |
(0.3) |
(0.2) |
(0.2) |
0.0 |
0.0 |
0.0 |
||||
Other |
0 |
(0) |
(0) |
(0) |
0.2 |
(0.6) |
0.2 |
0 |
0 |
0 |
(0) |
||||
Closing net debt/(cash) |
|
|
15.0 |
31.3 |
29.7 |
41.2 |
(0.3) |
(6.1) |
(18.4) |
(32.4) |
(34.0) |
(45.2) |
(57.4) |
||
Source: Severfield accounts, Edison Investment Research
|
|
BioLight reported H117 results in late August and IOPtiMate revenue was lower than expected, due to a pause in distributor activity in China. This interruption may last until there is a definitive conclusion in the pending Chengdu transaction. We have decreased our near-term IOPtiMate forecasts and extended the time runway estimated to achieve our peak sales targets for the product. We now derive an rNPV of NIS109.7-130.7m (down from NIS121.6-135.7m, previously).